Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Neuron|February 15, 2011
Huntington's disease: can mice lead the way to treatment?Zachary R Crook, David HousmanProceedings of the National Academy of Sciences of the United States of America|April 25, 2012
Dysregulation of dopamine receptor D2 as a sensitive measure for Huntington disease pathology in model miceZachary R Crook, David E HousmanJournal of Huntington'S Disease|July 27, 2014
Surveying the landscape of Huntington's disease mechanisms, measurements, and medicinesZachary R Crook, David E HousmanJournal of Huntington'S Disease|July 27, 2014
In vivo identification of therapeutic constructs from pooled candidates in HD model miceZachary R Crook, David E HousmanTrends in Biochemical Sciences|February 5, 2020
Miniproteins as a Powerful Modality in Drug DevelopmentZachary R Crook, Natalie W Nairn, James M OlsonMethods in Molecular Biology (Clifton, N.J.)|October 19, 2019
Mammalian Surface Display Screening of Diverse Cystine-Dense Peptide Libraries for Difficult-to-Drug TargetsZachary R Crook, Gregory P Sevilla, Andrew J Mhyre, et al.Biorxiv : the Preprint Server for Biology|May 7, 2024
CYpHER: Catalytic extracellular targeted protein degradation with high potency and durable effectZachary R Crook, Gregory P Sevilla, Pamela Young, et al.Nature Communications|October 9, 2024
CYpHER: catalytic extracellular targeted protein degradation with high potency and durable effectZachary R Crook, Gregory P Sevilla, Pamela Young, et al.Nature Communications|December 23, 2017
Mammalian display screening of diverse cystine-dense peptides for difficult to drug targetsZachary R Crook, Gregory P Sevilla, Della Friend, et al.Nature Communications|March 11, 2018
Publisher Correction: Mammalian display screening of diverse cystine-dense peptides for difficult to drug targetsZachary R Crook, Gregory P Sevilla, Della Friend, et al.Pageof 2